- Home
- GRI vs AREB Comparison
GRI vs AREB Comparison
Compare GRI & AREB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRI
- AREB
- Stock Information
- Founded
- GRI 2018
- AREB 2014
- Country
- GRI United States
- AREB United States
- Employees
- GRI N/A
- AREB N/A
- Industry
- GRI Biotechnology: Pharmaceutical Preparations
- AREB Plastic Products
- Sector
- GRI Health Care
- AREB Industrials
- Exchange
- GRI Nasdaq
- AREB Nasdaq
- Market Cap
- GRI 3.0M
- AREB 2.7M
- IPO Year
- GRI N/A
- AREB N/A
- Fundamental
- Price
- GRI $0.77
- AREB $2.52
- Analyst Decision
- GRI Strong Buy
- AREB
- Analyst Count
- GRI 1
- AREB 0
- Target Price
- GRI $12.00
- AREB N/A
- AVG Volume (30 Days)
- GRI 9.9M
- AREB 1.8M
- Earning Date
- GRI 11-14-2024
- AREB 11-12-2024
- Dividend Yield
- GRI N/A
- AREB N/A
- EPS Growth
- GRI N/A
- AREB N/A
- EPS
- GRI N/A
- AREB N/A
- Revenue
- GRI N/A
- AREB $15,454,870.00
- Revenue This Year
- GRI N/A
- AREB $45.19
- Revenue Next Year
- GRI N/A
- AREB N/A
- P/E Ratio
- GRI N/A
- AREB N/A
- Revenue Growth
- GRI N/A
- AREB N/A
- 52 Week Low
- GRI $0.30
- AREB $1.90
- 52 Week High
- GRI $106.29
- AREB $9.27
- Technical
- Relative Strength Index (RSI)
- GRI 49.32
- AREB 41.27
- Support Level
- GRI $0.79
- AREB $2.76
- Resistance Level
- GRI $1.00
- AREB $3.33
- Average True Range (ATR)
- GRI 0.17
- AREB 0.40
- MACD
- GRI -0.02
- AREB 0.03
- Stochastic Oscillator
- GRI 24.95
- AREB 12.14
About GRI GRI Bio Inc.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist, for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
About AREB American Rebel Holdings Inc.
American Rebel Holdings Inc develops self-defense, safe storage, and patriotic products. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, vault doors, and Others.